Microsoft PowerPoint - PolyOne Investor Presentation 5.4.20_v8 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • P E O P L E P R O D U C T S P L A N E T P E R F O R M A N C E •• •• •• JVs Performance Products & Solutions Distribution Specialty     To be the world’s premier provider of specialized polymer materials, services and solutions To be the world’s premier provider of specialized polymer materials, services and sustainable solutions • • • • • • • • • • • • • • 2016 2017 2018 2019 Lightweighting Reduced Material Requirements Improved Recyclability Renewable Energy Applications Eco-conscious Bio-derived Content Reduced Energy Use VOC Reduction $275M $325M $355M $410M 14% Total Annual Growth 9% Organic Annual Growth PolyOne Corporation 33 Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to PolyOne shareholders, excluding special items, to assess performance and facilitate comparability of results.

Factors that could cause actual results to differ materially from those implied by these forward looking statements include but are not limited to:• Factors that could cause actual results to differ materially from those implied by these forward‐looking statements include, but are not limited to:  Our ability to achieve the strategic and other objectives relating to the Spartech acquisition, including any expected synergies; our ability to successfully  integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and  cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate  liquidity) to maintain their credit availability;liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The amount and timing of repurchases, if any, of PolyOne common shares and our ability to pay regular quarterly cash dividends and the amounts and  timing of any future dividends;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;g p y p g ;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital  reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;, , p y p y g , y p p ;  An inability to maintain appropriate relations with unions and employees; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and  changes in the rate of inflation. • The above list of factors is not exhaustive. • We undertake no obligation to publicly update forward‐looking statements, whether as a result of new information, future events or otherwise.   The non‐GAAP financial measures  i l d dj t d EPS i b f i t t t d i ti dinclude: adjusted EPS, earnings before interest, tax, depreciation and  amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating  income, Specialty platform gross margin percentage, adjusted operating income,  return on invested capital, net debt/ EBITDA, and the exclusion of corporate p p charges in certain calculations.    • A reconciliation of each non‐GAAP financial measure with the most directly  comparable GAAP financial measure is attached to this presentation which is co pa ab e G a c a easu e s attac ed to t s p ese tat o c s posted on our website at www.polyone.com. 

Microsoft PowerPoint - AVNT Fermium Conference - May 2023 AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) M A Y 4 , 2 0 2 3 H O S T E D B Y : D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 36 79 87 83 81 76 73 90 79 77 76 73 69 60 22 A vi e n t K W R P P G F U L A V Y R P M F M C C E H X L A S H E C L H U N E M N S C L M U LT I P L E E X PA N S I O N Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of April 28, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.51. Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 37 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.9 14.6 13.7 13.0 11.9 8.8 18.7 17.4 11.8 10.0 9.7 9.1 8.0 7.9 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 8 ) A vi e n t (2 0 2 3 ) K W R P P G R P M A V Y F U L E C L H X L F M C A S H S C L C E E M N H U N Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

D is t. ) K W R P P G A V Y F U L R P M G C P F M C H X L H U N E C L A S H E M N C E S C L Source: Peer data per Bloomberg market data as of November 8, 2021 Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA H I G H F R E E C A S H F L OW C O N V E R S I O N Avient reflects 2021 estimated EBITDA of $580M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Source: Peer data per Bloomberg market data as of November 8, 2021 86 93 85 83 79 77 75 89 85 83 81 79 79 78 77 74 25 A vi e n t K W R P P G A V Y F U L R P M G C P F M C U N V R C E B N R H X L A S H E C L E M N H U N S C L A L B (10) Source: Peer data per Bloomberg market data as of November 8, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below many of our specialty formulator peers. With the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 33 Avient reflects 2021 estimated EBITDA of $580M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 11.4 20.2 16.7 16.5 14.7 12.0 10.8 40.7 29.9 26.2 13.2 12.4 11.0 10.9 9.1 9.0 7.5 6.5 A vi e n t K W R P P G A V Y R P M F U L G C P A L B H X L E C L A S H F M C B N R S C L U N V R E M N C E H U N S U M M A RY: W H Y I N V E S T I N AV I E N T ?

EXTRUSION FILM MANUFACTURER S I G N B O A R D P R O T E C T I V E T A P E • Film application with a high concentration of TIO2 (>80%) • Good performance on light fastness and anti-yellowing OnColor Polymer Colorants KEY REQUIREMENTS WHY AVIENT?

S A F E T Y E Q U I P M E N T M A N U FAC T U R E R M I L I T A R Y H E L M E T P A R T S • High impact resistance • RAL 6031 – military green color • High molecular weight • Met impact resistance requirements for military helmets • Delivered strong collaboration with Avient Design team and service • Provided specific RAL color matching for military application Bergamid™ Polymer Formulations KEY REQUIREMENTS WHY AVIENT?

LU X U RY PAC K AG IN G M A NUFAC TUR ER S P I R I T B O T T L E C A P S • Specific gravity of 1.6 • EU and FDA compliant material • ABS-based material suitable for electroplating • Delivered a customized density polymer that supported electroplating, resulting in both the look and feel of metal • Demonstrated experience and expertise in density-modified material technology and electroplating to reach application goals quickly and cost-effectively Gravi-Tech™ Density Modified Formulation KEY REQUIREMENTS WHY AVIENT?

SURGICAL DEVICE MANUFACTURER H A N D L E H O U S I N G F O R L A P A R O S C O P I C S E A L E R • Excellent adhesion onto PC/ABS • Good aesthetics with soft touch • RoHS, REACH and FDA compliant • Enhanced ergonomics and functionality with improved soft grip • Met performance requirements for wear resistance and colorability • Customized a thermoplastic elastomer (TPE) solution and had with a faster sample response speed than competitor Versaflex™ Overmolding Formulation KEY REQUIREMENTS WHY AVIENT?

PRE-FILLED SYRINGE COMPANY S Y R I N G E T I P C A P • Excellent sealing performance • No DEHP or natural rubber latex added during processing • Can be sterilized by EtO • Compliant with ISO 10993-4&5 and USP Class VI • Formulated a solution that met rigorous medical application requirements • Leveraged global footprint to ensure supply continuity • Increased process efficiency by replacing previous thermoset material with a TPE Versaflex™ HC Thermoplastic Elastomers KEY REQUIREMENTS WHY AVIENT?

S M A L L A P P L I A N C E O E M C O F F E E M A C H I N E S E A L • Soft durometers • Good bonding to ABS • Good flowability for easy processing • Excellent sealing property • Formulated a 30 Shore A TPE with excellent peel force performance to meet the sealing requirements • Offered a short lead time and on-site technical service to speed up the time to market • Provided fast global collaboration between regions, supporting the brand’s design team in Europe and molders in Asia Custom VersaflexTM Formulation KEY REQUIREMENTS WHY AVIENT?